LRP6

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Low-density lipoprotein receptor-related protein 6 is a protein that in humans is encoded by the LRP6 gene. LRP6 is a key component of the LRP5/LRP6/Frizzled co-receptor group that is involved in canonical Wnt pathway.

Low-density lipoprotein receptor-related protein 6 is a protein that in humans is encoded by the LRP6 gene. LRP6 is a key component of the LRP5/LRP6/Frizzled co-receptor group that is involved in canonical Wnt pathway.

Clinical significance

Common genetic variants of LRP6 have been associated with the risks for hyperlipidemia, atherosclerosis, coronary disease, and late-onset Alzheimer's disease in the general population. Loss-of-function mutations or LRP6 in humans lead to increased plasma LDL and triglycerides, hypertension, diabetes and osteoporosis. Similarly, mice with a loss-of-function Lrp6 mutation have low bone mass. LRP6 is critical in bone's anabolic response to parathyroid hormone (PTH) treatment, whereas LRP5 is not involved. On the other hand, LRP6 does not appear active in mechanotransduction (bone's response to forces), while LRP5 is critical in that role. Sclerostin, one of the inhibitors of LRP6, is a promising osteocyte-specific Wnt antagonist in osteoporosis clinical trials.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1351152417 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001351152417 · captured 1777177966.0 · version history

Cite this page as: encyclopegia.org, “LRP6”, snapshot enwiki-001351152417. https://encyclopegia.org/a/lrp6

Sources cited in this revision

Extracted from the cited revision's reference blocks; absent citations are not invented.